bf/NASDAQ:ZYXI_icon.jpeg

NASDAQ:ZYXI

Zynex Medical

  • Stock

2.01

+21.08%

0.46

USD last updated 18/09 01:49:32

Last Close

1.55

18/09 20:00

Market Cap

285.34M

Beta: 0.59

Volume Today

644.22K

Avg: 340.50K

PE Ratio

26.14

PFCF: 25.52

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
11.12M
-
11.64M
4.71%
13.31M
14.36%
23.43M
76.01%
31.92M
36.21%
45.47M
42.47%
80.12M
76.20%
130.30M
62.63%
158.17M
21.39%
184.32M
16.54%
192.35M
4.36%
cost of revenue
7.61M
-
4.94M
35.14%
3.52M
28.76%
4.82M
37.02%
6.04M
25.30%
8.81M
45.98%
17.42M
97.61%
27.32M
56.86%
32.01M
17.14%
38.37M
19.88%
39.43M
2.77%
gross profit
3.50M
-
6.70M
91.27%
9.80M
46.12%
18.61M
90.01%
25.88M
39.04%
36.66M
41.65%
62.70M
71.05%
102.98M
64.23%
126.16M
22.51%
145.96M
15.69%
152.93M
4.77%
selling and marketing expenses
14.02M
-
34.13M
143.53%
54.29M
59.05%
67.12M
23.62%
86.66M
29.12%
86.58M
0.09%
general and administrative expenses
11.58M
-
18.32M
58.28%
26.32M
43.67%
36.11M
37.17%
48.52M
34.37%
60.35M
24.40%
selling general and administrative expenses
11.40M
-
9.19M
19.41%
9.16M
0.32%
9.67M
5.60%
15.51M
60.40%
25.59M
65.01%
52.46M
104.97%
80.61M
53.68%
103.22M
28.05%
125.98M
22.04%
146.94M
16.64%
research and development expenses
9.20M
-
other expenses
-47K
-
-7K
85.11%
-204K
2,814.29%
880K
-
-77K
108.75%
cost and expenses
16.81M
-
14.12M
16.01%
12.67M
10.26%
14.49M
14.32%
21.55M
48.72%
34.41M
59.68%
69.87M
103.08%
107.94M
54.47%
135.23M
25.29%
173.54M
28.33%
186.36M
7.39%
operating expenses
9.20M
-
9.19M
0.18%
9.16M
0.32%
9.67M
5.60%
15.51M
60.40%
25.59M
65.01%
52.46M
104.97%
80.61M
53.68%
103.22M
28.05%
135.18M
30.95%
146.94M
8.70%
interest expense
536K
-
503K
6.16%
352K
30.02%
1.45M
311.93%
154K
89.38%
5K
96.75%
19K
280%
95K
400%
440K
363.16%
1.09M
148.64%
2.38M
117.73%
ebitda
-5.08M
-
-2.06M
59.40%
871K
142.20%
8.94M
926.87%
10.37M
15.94%
11.07M
6.71%
11.74M
6.13%
22.37M
90.45%
22.94M
2.56%
15M
34.61%
10.79M
28.06%
operating income
-5.70M
-
-2.48M
56.45%
640K
125.80%
8.94M
1,297.50%
10.37M
15.94%
11.07M
6.71%
10.25M
7.38%
22.37M
118.23%
22.94M
2.56%
10.78M
53.00%
5.99M
44.43%
depreciation and amortization
660K
-
424K
35.76%
435K
2.59%
286K
34.25%
448K
56.64%
778K
73.66%
1.50M
92.16%
2.29M
52.91%
3.13M
36.79%
4.22M
34.95%
4.78M
13.32%
total other income expenses net
-47K
-
-7K
85.11%
-204K
2,814.29%
-1.45M
610.78%
-154K
89.38%
875K
668.18%
-96K
110.97%
-95K
1.04%
-740K
678.95%
1.80M
343.11%
-2.36M
231.35%
income before tax
-6.28M
-
-2.99M
52.37%
84K
102.81%
7.49M
8,821.43%
10.22M
36.32%
11.94M
16.89%
10.15M
14.97%
22.27M
119.35%
22.20M
0.33%
12.58M
43.33%
3.63M
71.17%
income tax expense
-49K
-
-57K
16.33%
15K
126.32%
129K
760%
664K
414.73%
2.45M
268.83%
1.08M
55.94%
5.17M
378.96%
5.15M
0.35%
2.85M
44.72%
633K
77.77%
net income
-6.20M
-
-2.91M
53.04%
69K
102.37%
7.37M
10,573.91%
9.55M
29.69%
9.49M
0.63%
9.07M
4.40%
17.10M
88.48%
17.05M
0.32%
9.73M
42.91%
2.99M
69.24%
weighted average shs out
34.33M
-
34.40M
0.20%
34.40M
0.00%
35.37M
2.83%
35.75M
1.08%
35.68M
0.20%
37.26M
4.41%
38.32M
2.85%
38.47M
0.39%
35.55M
7.57%
31.94M
10.16%
weighted average shs out dil
34.33M
-
34.40M
0.20%
34.40M
0.00%
36.52M
6.16%
37.45M
2.55%
37.36M
0.23%
38.44M
2.89%
39.20M
1.97%
39.13M
0.18%
36.14M
7.63%
32.30M
10.63%
eps
-0.18
-
-0.08
53%
0.00
102.36%
0.21
10,400%
0.27
28.57%
0.26
3.70%
0.24
7.69%
0.45
87.50%
0.44
2.22%
0.27
38.64%
0.09
66.67%
epsdiluted
-0.18
-
-0.08
53%
0.00
102.36%
0.20
9,900%
0.26
30%
0.25
3.85%
0.24
4.00%
0.44
83.33%
0.44
0%
0.27
38.64%
0.09
66.67%

All numbers in USD (except ratios and percentages)